Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEIH.L Regulatory News (EIH)

  • There is currently no data for EIH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

30 Sep 2008 15:00

RNS Number : 7019E
Evolvence India Holdings PLC
30 September 2008
 



 

Evolvence India Holdings Announces its Net Asset Value as on 30 June 2008

Company's  net assets are US$ 58.68 million and NAV per share is US$ 0.903

Douglas, Isle of Man: 30 September 2008 - Evolvence India Holdings plc ("EIH" or "the Company"), (AIM: EIH.L.), an investment company that focuses on private equity in India, today announced its un-audited net asset value of US$ 0.903 per share as at 30 June 2008. 

The Company invests in India through the Evolvence India Fund ("EIF"), the Evolvence India Life Sciences Fund ("EILSF"), the fund managers' network of relationships and other investment opportunities.

Highlights:

The Company's net assets are US$ 58.68 million as at 30 June 2008

NAV per share is US$ 0.903 as at 30 June 2008 

Dividend of US$ 0.03 per share for the year ended 31 December 2007, was paid on 20 June 2008

Key Portfolio Updates:
·; EIF has invested into a real estate project and is committed to invest into an infrastructure focused private equity fund in India
·; Successful portfolio exits include a co-investment in an Indian private sector bank and from two portfolio companies of underlying funds
·; EIH has committed US$ 70.0 million, of which US$ 52.9 million has been deployed, to date. Cash distributions received amount to US$ 3.8 million, and dividend amounting to US$ 2.0 million has been distributed.

Khaled Al Muhairy, Chairman, Evolvence India Holdings commented: 

"Evolvence India Holding has produced results that reflect the effects of challenging market conditions. The fall in NAV reflects the decline in capital markets in India; but despite the volatility in capital markets and a global slowdown, the country's long term macro-economic fundamentals remain intact. However, short term borrowing costs are expected to remain firm and we believe this has increased the attractiveness of private equity funding for Indian companies. We will continue to selectively capitalise on the range of opportunities available in the Indian private equity market."

- Ends-

About Evolvence India Holding (EIH):

EIH is promoted by Evolvence Capital Ltd ("Evolvence Capital"), a leading alternative assets management company that focuses on the Middle East and South Asia. The company manages assets of approximately US$ 1.5 billion across three core asset classes of private equity, real estate and alterative capital markets.

Contacts:

Evolvence India Holdings plc

Khaled Al Muhairy, Chairman + (971) 4 315 81000

Evolvence Capital

Shilpa Mathai, Communications Director  + (971) 4 315 81000 

shilpa@evolvence.com

Seymour Pierce

Jonathan Wright, Director, Corporate Finance + (44) 20 7107 8050 

Fairfax I.S. PLC (Broker)

Ewan Leggat, Director, Equities + (44) 20 7598 5368

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVWUUCUBUPRGWU
Date   Source Headline
7th May 202011:49 amRNSResult of EGM and Notice of Cancellation
7th Apr 20207:00 amRNSProposed AIM Cancellation and Notice of EGM
2nd Apr 20205:38 pmRNSReturn of Capital and COVID-19 Update
6th Dec 20197:00 amRNSReturn of Capital
29th Nov 20197:00 amRNSDelisting Update
21st Nov 20197:00 amRNSMarket Update
30th Sep 20194:30 pmRNSInterim Results
30th Jul 201911:15 amRNSResult of AGM
28th Jun 20197:00 amRNSPosting of 2018 Annual Results and Notice of AGM
24th May 20195:53 pmRNSHolding(s) in Company
1st May 20197:00 amRNSReturn of Capital
4th Apr 20195:00 pmRNSSale of RSB and Return of Capital
25th Jan 20197:00 amRNSHolding(s) in Company
21st Jan 20196:13 pmRNSHolding(s) in Company
18th Jan 201911:37 amRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
26th Jul 201811:05 amRNSResult of AGM
28th Jun 20187:00 amRNSPosting of 2017 Annual Report and Notice of AGM
28th Jun 20187:00 amRNSReturn of Capital
20th Mar 20181:00 pmRNSReplacement: Return of Capital
20th Mar 20187:00 amRNSReturn of Capital
29th Sep 20175:17 pmRNSHalf-year Report
29th Sep 20175:13 pmRNSReturn of capital
24th Jul 201710:54 amRNSResults of Annual General Meeting
26th Jun 20176:01 pmRNSDirectorate Change
26th Jun 20176:00 pmRNSPosting of 2016 Annual Report and Notice of AGM
9th Feb 20178:05 amRNSReturn of Capital
26th Jan 20175:08 pmRNSHolding(s) in Company
25th Jan 20179:30 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSUpdate re EIF
30th Sep 20167:00 amRNSHalf-year Report
25th Jul 20161:24 pmRNSResult of AGM
27th Jun 20165:37 pmRNSPosting of Annual Report & Notice of AGM
27th Jun 20167:00 amRNSFinal Results
27th Jun 20167:00 amRNSReturn of Capital
30th Nov 20155:57 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
30th Jun 201511:53 amRNSResult of AGM
9th Jun 20154:00 pmRNSNotice of AGM
5th Jun 20154:35 pmRNSFinal Results
30th Sep 20147:00 amRNSHalf Yearly Report
14th Jul 20143:19 pmRNSReturn of Capital
30th Jun 201411:57 amRNSResult of AGM
4th Jun 20147:00 amRNSNotice of AGM
3rd Jun 20147:00 amRNSFinal Results
3rd Dec 201311:16 amRNSHolding(s) in Company
2nd Dec 20134:09 pmRNSHolding(s) in Company
28th Nov 20135:14 pmRNSHolding(s) in Company
27th Nov 20133:14 pmRNSSale of Interest in Gland Pharma Limited
22nd Nov 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.